Vikram Kotwal, MD
Gastroenterology · Decatur, ILNPI 1215267596
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.0%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Madrigal Pharmaceuticals at 35.4% of the total. 2025 is the largest year on record at $6,713, more than ten times the $641 reported in 2019.
Across 46 payments — averaging $187.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Madrigal Pharmaceuticals$3K
- Cook Incorporated$2K
- Boston Scientific$944
- Cook Medical LLC$876
- Gilead$464
- Intercept Pharmaceuticals, Inc.$149
- plus $890 from 10 others
What the payments were for
- Consulting fees$2,58030%
- Speaking & faculty fees$2,26026%
- Food & beverage$3,80544%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Madrigal Pharmaceuticals | 5 | $3,063 |
| Cook Incorporated | 1 | $2,260 |
| Boston Scientific | 10 | $944 |
| Cook Medical LLC | 10 | $876 |
| Gilead | 4 | $464 |
| Intercept Pharmaceuticals, Inc. | 1 | $149 |
| Phathom Pharmaceuticals, Inc. | 1 | $146 |
| Ipsen Biopharmaceuticals, Inc | 1 | $144 |
| AbbVie | 2 | $138 |
| QOL Medical, LLC | 1 | $128 |
| Apollo Endosurgery US Inc | 3 | $96 |
| Medtronic | 2 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $61 |
| Laborie Medical Technologies Corp. | 1 | $45 |
| Ardelyx, Inc. | 1 | $42 |
| Pfizer | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,645 in reported general payments places this provider in the 80th percentile of 787 gastroenterology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 18 | $270 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Decatur
- David RubinChicago$1.5M
- Stephen HanauerChicago$1.4M
- Steven FlammChicago$1.3M
- Amar NaikDes Plaines$1.2M
- Darren BrennerChicago$1.1M
- Jonathan RosenbergGurnee$1M
- Daksesh PatelEvanston$745K
- Russell CohenChicago$690K
- Parambir DulaiChicago$668K
- Christopher ChapmanChicago$645K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.